Cardio Incorporated

Cardio Incorporated (Cardio) is a privately held health care company. It is involved in maintaining and improving the life of patients with cardiovascular disorders through translational research encompassing cellular therapy, tissue engineering and drug discovery. Over the years, the company has established and expanded Kobe TRI Laboratories in the Translational Research Informatics Center, one of the core facilities of the Kobe Medical Industry Development Project and Kobe BMA Laboratories. The company is engaged in developing regenerative medicine which is aimed to provide a solution for damaged organs with the potential of radically altering the medicine. It has entered into collaborations with universities and other companies for conducting advanced research. In September 2009, the company announced private placement for $10.2 million. Cardio is headquartered in Osaka, Japan.

Street: 
Room No. 302, 4-15-5
City: 
Kita-ku
Postcode: 
530-0043
Federal State : 
Japan
WebSite: 
www.cardio.co.jp
Fax: 
81-6-63537348

Company Index Score

Current Index Score Historical Index Score
  • Cardio Incorporated currently scores 50 % in the index.
  • Cardio Incorporated is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Cardio Incorporated is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets